In HBV-related HCC, cytotoxic CD4+ T cells present similar numbers with cytotoxic CD8+ T cells, while they are less effective to eliminate tumor cells due to secreting less cytolytic factors such as granzyme A (GzmA) and granzyme B (GzmB). The gene discussed is CD4; the disease is neoplasm.